Insight Molecular Diagnostics Inc. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Insight Molecular Diagnostics Inc. (IMDX) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-03-26
- Insight Molecular Diagnostics Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Insight Molecular Diagnostics Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $1.40M.
- Insight Molecular Diagnostics Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2020 was $15.00K, a 99.05% decline from fiscal 2019.
- Insight Molecular Diagnostics Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2019 was $1.59M.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 |
| 2024-12-31 | $1.40M 10-K · filed 2026-03-26 |
| 2020-12-31 | $15.00K 10-K · filed 2022-03-11 |
| 2019-12-31 | $1.59M 10-K · filed 2021-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |